Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT trial of methotrexate versus ciclosporin for severe atopic eczema in children
2015-002013-29Phase 3Unknown
- Sponsor
- King's College London
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in atopic dermatitis (AD) comparing Methotrexate with Ciclosporin (2 arms). Primary endpoint: Change in atopic eczema severity using oSCORAD from baseline to 12 weeks. Status: unknown.
02
Drugs
methotrexatecyclosporine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2015-002013-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002013-29.